H. AKKIZ Et Al. , "Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study," CANCER EPIDEMIOLOGY , vol.34, no.3, pp.298-302, 2010
AKKIZ, H. Et Al. 2010. Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study. CANCER EPIDEMIOLOGY , vol.34, no.3 , 298-302.
AKKIZ, H., Bayram, S., Bekar, A., Akgollu, E., & Ozdil, B., (2010). Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study. CANCER EPIDEMIOLOGY , vol.34, no.3, 298-302.
AKKIZ, HİKMET Et Al. "Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study," CANCER EPIDEMIOLOGY , vol.34, no.3, 298-302, 2010
AKKIZ, HİKMET Et Al. "Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study." CANCER EPIDEMIOLOGY , vol.34, no.3, pp.298-302, 2010
AKKIZ, H. Et Al. (2010) . "Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study." CANCER EPIDEMIOLOGY , vol.34, no.3, pp.298-302.
@article{article, author={HİKMET AKKIZ Et Al. }, title={Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study}, journal={CANCER EPIDEMIOLOGY}, year=2010, pages={298-302} }